Second primary cancers related to smoking and treatment of small-cell lung cancer

Journal of the National Cancer Institute

Volumn 89, Issue 23, 1997, Pages 1782-1788

  Tucker, Margaret A ^a,l   Murray, Nevin ^b   Shaw, Edward G ^c,m   Ettinger, David S ^d   Mabry, Mack ^d   Huber, Martin H ^e   Feld, Ronald ^f   Shepherd, Frances A ^g   Johnson, David H ^h   Grant, Stefan C ⁱ   Aisner, Joseph ^j   Johnson, Bruce E ^k  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c MAYO CLINIC   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e Rhone Poulenc Rorer   (United States)

^f PRINCESS MARGARET HOSPITAL   (Canada)

^g UNIVERSITY HEALTH NETWORK   (Canada)

^h VANDERBILT UNIVERSITY   (United States)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^j RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^k NCI   (United States)

^l NATIONAL INSTITUTES OF HEALTH   (United States)

^m WAKE FOREST SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CISPLATIN; NITROSOUREA DERIVATIVE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; SECOND CANCER; SMOKING;

EID: 0030724601     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.23.1782     Document Type: Article

References (28)

1. Richardson GE, Tucker MA, Venzon DJ, Linnoila RI, Phelps R, Phares JC, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 1993;119:383-90.
2. Johnson BE, Linnoila RI, Williams JP, Venzon DJ, Okunieff P, Anderson GB, et al. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. J Clin Oncol 1995;13:101-11.
3. Sagman U, Lishner M, Maki E, Shepherd FA, Haddad R, Evans WK, et al. Second primary malignancies following diagnosis of small-cell lung cancer. J Clin Oncol 1992;10:1525-33.
4. Heyne KH, Lippman SM, Lee JJ, Lee JS, Hong WK. The incidence of second primary tumors in long-term survivors of small-cell lung cancer. J Clin Oncol 1992;10:1519-24.
5. Lassen U, Osterlind K, Hansen M, Dombernowsky P, Bergman B, Hansen HH. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years-an analysis of 1,714 consecutive patients. J Clin Oncol 1995;13:1215-20.
6. Souhami RL, Law K. Longevity in small-cell lung cancer. A report to the lung cancer subcommittee of the United Kingdom Coordinating Committee for Cancer Research. Br J Cancer 1990;61:584-9.
7. Chak LY, Sikic BI, Tucker MA, Horns RC Jr, Cox RS. Increased incidence of acute nonlymphocytic leukemia following therapy in patients with small-cell carcinoma of the lung. J Clin Oncol 1984;2:385-90.
8. Pedersen-Bjergaard J, Osterlind K, Hansen M, Philip P, Pedersen AG, Hansen HH. Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small-cell carcinoma of the lung. Blood 1985;66:1393-7.
9. Travis LB, Curtis RE, Hankey BJ, Fraumeni JF Jr. Acute nonlymphocytic leukemia after small-cell lung cancer [letter]. J Clin Oncol 1993;11:586-7.
10. Albain KS, Crowley JJ, Livingston RB. Long-term survival and toxicity in small-cell lung cancer: expanded Southwest Oncology Group experience. Chest 1991;99:1425-32.
11. Ihde DC, Pass HI, Glatstein EJ. Small-cell lung cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 4th ed. Philadelphia: Lippincott-Raven, 1993:723-58.
12. Monson RR. Analysis of relative survival and proportional mortality. Comput Biomed Res 1974;7:325-32.
13. Ries LA, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, editors. SEER cancer statistics review, 1973-1991: tables and graphs, National Cancer Institute. NIH Publ No. 94-2789. Bethesda (MD), 1994.
14. Boice JD Jr, Lubin JH, Preston DL. EPITOME: epidemiologic analysis with a personal computer. NIH Publ 96-3180. US Govt Print Off. Washington (DC), 1996.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
16. th ed. Cary (NC): SAS Institute Inc., 1989:997-1025.
17. Tucker MA. Secondary cancers. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 4th ed. Philadelphia: Lippincott-Raven, 1993:2407-16.
18. van Leeuven FE, Klokman WJ, Stovall M, Hagenbeek, van den Belt-Dusebout AW, Noyon R, et al. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst 1995;87:1530-7.
19. Kaldor JM, Day NE, Bell J, Clarke EA, Langmark F, Karjalainen S, et al. Lung cancer following Hodgkin's disease: a case-control study. Int J Cancer 1992;52:677-81.
20. Swerdlow AJ, Douglas AJ, Hudson GV, Hudson BV, Bennett MH, Mac-Lennan KA. Risk of second primary cancer after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. BMJ 1992;304:1137-43.
21. Inskip PD, Stovall M, Flannery JT. Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 1994;86:983-8.
22. Lubin JH, Boice JD Jr, Edling C, Hornung RW, Howe GR, Kunz E, et al. Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. J Natl Cancer Inst 1995;11:817-27.
23. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993;85:25-31.
24. Boice JD Jr, Greene MH, Killen JY, Ellenberg SS, Fraumeni JF Jr, Keehn RJ, et al. Leukemia after chemotherapy with semustine (methyl-CCNU)-evidence of a dose-response effect [letter]. N Engl J Med 1986;314:119-20.
25. Ihde DC, Tucker MA. Second primary malignancies in small-cell lung cancer: a major consequence of modest success [editorial]. J Clin Oncol 1992;10:1511-3.
26. Hancock SL, Tucker MA, Hoppe RT. Factors affecting the late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993;270: 1949-55.
27. Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Firket P, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993;11:1216-22.
28. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol 1994;12:851-73.